InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Friday, 10/19/2018 12:47:29 PM

Friday, October 19, 2018 12:47:29 PM

Post# of 108192
Since we haven't received (and probably will not) an enrollment update on NEO anyone have a guesstimate on where they are. First dosing was announced in June. There are three cohorts of three patients each for three indications with a staggering of dosing by at least four weeks for the first cohort (safety protocol?). So is it reasonable that all three should be dosed in the first cohort? And how hard could it possibly be to send out a blurb that dosing is proceeding as expected unless Amgen has a qualm with that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News